Healthcare provider profile · identity verified

Deanna Michaelis, FNP

Nurse Practitioner · FORREST CITY, AR · NPI 1265949895

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	522	90
Tramadol Hcl	Tramadol Hcl	230	34
Amlodipine Besylate	Amlodipine Besylate	216	63
Meloxicam	Meloxicam	214	56
Alprazolam	Alprazolam	200	37
Omeprazole	Omeprazole	199	56
Atorvastatin Calcium	Atorvastatin Calcium	189	55
Mounjaro	Tirzepatide	189	36
Lisinopril	Lisinopril	159	40
Losartan Potassium	Losartan Potassium	140	37
Pantoprazole Sodium	Pantoprazole Sodium	118	26
Simvastatin	Simvastatin	114	36
Furosemide	Furosemide	106	33
Metformin Hcl	Metformin Hcl	94	28
Metoprolol Succinate	Metoprolol Succinate	89	18
Gabapentin	Gabapentin	85	25
Clopidogrel	Clopidogrel Bisulfate	84	25
Albuterol Sulfate Hfa	Albuterol Sulfate	83	37
Fluticasone Propionate	Fluticasone Propionate	77	36
Metoprolol Tartrate	Metoprolol Tartrate	75	24
Pregabalin	Pregabalin	74	22
Zolpidem Tartrate	Zolpidem Tartrate	72	15
Linzess	Linaclotide	69	26
Glipizide	Glipizide	67	19
Levothyroxine Sodium	Levothyroxine Sodium	65	23
Potassium Chloride	Potassium Chloride	65	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	63	27
Allopurinol	Allopurinol	59	15
Tamsulosin Hcl	Tamsulosin Hcl	56	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	54	12
Ondansetron Odt	Ondansetron	52	28
Azithromycin	Azithromycin	50	44
Duloxetine Hcl	Duloxetine Hcl	50	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	50	12
Fenofibrate	Fenofibrate	48	14
Fluoxetine Hcl	Fluoxetine Hcl	48	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	48	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	47	14
Trazodone Hcl	Trazodone Hcl	46	18
Diclofenac Sodium	Diclofenac Sodium	45	18
Hydrochlorothiazide	Hydrochlorothiazide	44	23
Triamcinolone Acetonide	Triamcinolone Acetonide	43	30
Prednisone	Prednisone	42	23
Fluconazole	Fluconazole	41	22
Oxybutynin Chloride Er	Oxybutynin Chloride	41	14
Carvedilol	Carvedilol	39	14
Metformin Hcl Er	Metformin Hcl	39	13
Temazepam	Temazepam	38	suppressed
Tizanidine Hcl	Tizanidine Hcl	38	suppressed
Celecoxib	Celecoxib	37	suppressed
Alendronate Sodium	Alendronate Sodium	36	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	36	suppressed
Eliquis	Apixaban	35	suppressed
Ropinirole Hcl	Ropinirole Hcl	34	suppressed
Amoxicillin	Amoxicillin	33	26
Dexamethasone	Dexamethasone	33	29
Pravastatin Sodium	Pravastatin Sodium	33	suppressed
Atenolol	Atenolol	32	13
Synjardy Xr	Empagliflozin/Metformin Hcl	32	suppressed
Ezetimibe	Ezetimibe	31	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	31	suppressed
Ibuprofen	Ibuprofen	30	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	23
Hydralazine Hcl	Hydralazine Hcl	28	suppressed
Jardiance	Empagliflozin	28	11
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Clonazepam	Clonazepam	27	suppressed
Methocarbamol	Methocarbamol	27	suppressed
Nifedipine Er	Nifedipine	27	suppressed
Sertraline Hcl	Sertraline Hcl	26	suppressed
Lorazepam	Lorazepam	24	suppressed
Montelukast Sodium	Montelukast Sodium	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	23	suppressed
Glipizide Er	Glipizide	23	suppressed
Spironolactone	Spironolactone	23	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	22	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Citalopram Hbr	Citalopram Hydrobromide	22	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Nystatin	Nystatin	21	11
Synjardy	Empagliflozin/Metformin Hcl	21	suppressed
Januvia	Sitagliptin Phosphate	20	suppressed
Levofloxacin	Levofloxacin	19	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	18	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	15
Diazepam	Diazepam	17	suppressed
Promethazine Hcl	Promethazine Hcl	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Torsemide	Torsemide	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	17	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	16	suppressed
Glimepiride	Glimepiride	16	suppressed
Nebivolol Hcl	Nebivolol Hcl	16	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	16	14
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	13
Clindamycin Hcl	Clindamycin Hcl	15	14
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	12
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Carisoprodol	Carisoprodol	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Finasteride	Finasteride	14	suppressed
Ramipril	Ramipril	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Methylprednisolone	Methylprednisolone	13	11
Mupirocin	Mupirocin	13	12
Nitroglycerin Patch	Nitroglycerin	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	12
Methotrexate	Methotrexate Sodium	12	suppressed
Phenelzine Sulfate	Phenelzine Sulfate	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Captopril	Captopril	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Sotalol	Sotalol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error